Practical guides for physicians, NPs, PAs and nurses on IV therapy, peptides, regenerative medicine and the business of practicing beyond insurance.

Two 2026 reviews find no clear evidence PRP rebuilds knee cartilage, with low-certainty symptom gains. What clinicians can honestly claim.

The peptide shift hasn't changed FDA rules for stem cells or exosomes. What's approved, what's not, and the compliance checklist for clinicians.

What FDA's interim peptide compounding policy and the July PCAC vote actually change for your practice, and what's still not legal to compound.

A murder indictment, a wrongful-death suit, and Indiana's med-spa registration law: what the criminal and civil ceiling of IV therapy looks like in 2026.